So-called "pay for delay" deals between patent-holding pharmaceutical firms and would-be generics makers can now be challenged on antitrust grounds, although they are not necessarily anti-competitive, the U.S. Supreme Court has ruled.
Payers and employers are demonstrating that wellness programs can curb increases in healthcare costs and improve workforce productivity as employees become more involved in their health.
Editorial
Robert Laszewski, Health Care Policy and Marketplace Review
Last week, I received my weekly email update from the Maryland health insurance exchange:
Judy Hanover, Research Director, IDC Health Insights
In recent publicized efforts to get more information to patients about their own medical history, the OpenNotes effort has resulted in providers adding access to physician's notes in online portals at 3 high profile U.S. healthcare organizations.
9(unknown*no*no*1)&guid=ON&x_utmac=MO-331855-25){kind=small}
